The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.

Entering his 15th Major League season, the seven-time All-Star and 2022 National League MVP replaces Jose Trevino as the ...

The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer ...

Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...

A psychiatrist and a patient respond to an article in Science Times. Also: A plea to Congress; an upside-down definition of ...

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.

March 20 marks the first day of spring, but more importantly, it's your chance to snag a free ice cream cone at Dairy Queen.

One in four adults prescribed stimulants misuse them, and nearly 1 in 10 develop an addiction to these medications — underscoring the need for better screening.